Robert E. Haupt
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- SARS-CoV-2 and COVID-19 Research 11
-
- Influenza Virus Research Studies 2
- Co-authors
- Matthew B. Frieman (5 shared papers)Christopher M. Coleman (1 shared paper)James Logue (2 shared papers)Susan Reich Weiss (1 shared paper)Yize Li (1 shared paper)Stuart M. Weston (2 shared papers)Krystal L. Matthews (1 shared paper)Florian Krammer (2 shared papers)
- Journals
- Nature Communications (3 papers)Science (2 papers)Scientific Reports (2 papers)Science Translational Medicine (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert E. Haupt
13 papers receiving 3.6k citations
Robert E. Haupt's Hit Papers
Peers
Comparison fields: 5 of 105
- Infectious Diseases 2.7k
- Immunology 203
- Computational Theory and Mathematics 151
- Biomedical Engineering 244
- Molecular Biology 409
Countries citing papers authored by Robert E. Haupt
This map shows the geographic impact of Robert E. Haupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Haupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Haupt more than expected).
Fields of papers citing papers by Robert E. Haupt
This network shows the impact of papers produced by Robert E. Haupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Haupt. The network helps show where Robert E. Haupt may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Haupt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Hit paper breakdown → | 2020 | 955 |
| 2 | Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail Hit paper breakdown → | 2020 | 937 |
| 3 | 2020 | 551 | |
| 4 | SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice Hit paper breakdown → | 2021 | 391 |
| 5 | A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics Hit paper breakdown → | 2021 | 341 |
| 6 | 2021 | 237 | |
| 7 | 2020 | 194 | |
| 8 | 2022 | 99 | |
| 9 | 2021 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 4 |
About Robert E. Haupt
Robert E. Haupt is a scholar working on Infectious Diseases, Epidemiology, Biomedical Engineering, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 13 papers that have together received 3.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), Influenza Virus Research Studies (2 papers) and 3D Printing in Biomedical Research (1 paper). The work is most often cited by research in Infectious Diseases (2.7k citations), Immunology (203 citations), Computational Theory and Mathematics (151 citations), Biomedical Engineering (244 citations) and Molecular Biology (409 citations). Robert E. Haupt has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Matthew B. Frieman, Christopher M. Coleman, James Logue, Susan Reich Weiss, Yize Li, Stuart M. Weston, Krystal L. Matthews, Florian Krammer, Erin M. Harberts and Robert K. Ernst. Their work appears in journals such as Nature Communications, Science, Scientific Reports, Science Translational Medicine and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.